Generate a tailored SOP for Dr. Yueming Li. Improve your application with a focused, well-structured draft.
Yueming Li is a Biochemist at the Sloan Kettering Institute. His research focuses on basic and translational research in cancer and Alzheimer's disease, emphasizing disease mechanisms and therapeutic development. His lab studies target identification, drug discovery, chemical biology, medicinal chemistry, biochemistry, enzymology, biophysics, structural biology, neurobiology, neuroinflammation, and autophagy, as well as protein aggregation and clearance. Yueming Li aims to develop new agents that inhibit specific intramembrane proteases associated with cancer. He has published various significant studies linking inflammation and the development of Alzheimer's disease, suggesting innovative ways to aid diagnosis and treatment.
The program is hosted by the Weill Cornell Graduate School of Medical Sciences in partnership with the Sloan Kettering Institute. GRE scores are optional.